SK Inc 2019 SR
The report highlights SK holdings' 2018 performance and its transition toward a global investment holdings company focused on creating both economic and social value through Double Bottom Line management. Key achievements include the development of the epilepsy drug Cenobamate, expansion into the North American shale gas market, and significant investments in digital transformation. The company quantified its social value creation for the first time, totaling KRW 834.8 billion across economic contributions, business performance, and social contributions. It also emphasizes its commitment to the UN SDGs and its inclusion in the DJSI World for seven consecutive years.
Company: SK Inc
Sector: Finance & insurance
Country: South Korea
Year: 2019
Type: SR
Pages: 86
SK Inc
The report highlights SK holdings' 2018 performance and its transition toward a global investment holdings company focused on creating both economic and social value through Double Bottom Line management. Key achievements include the development of the epilepsy drug Cenobamate, expansion into the North American shale gas market, and significant investments in digital transformation. The company quantified its social value creation for the first time, totaling KRW 834.8 billion across economic contributions, business performance, and social contributions. It also emphasizes its commitment to the UN SDGs and its inclusion in the DJSI World for seven consecutive years.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Jan 1, 2018 - Dec 31, 2018
Fiscal Year
2018
Published
Jul 1, 2019
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees